These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 5307055)

  • 1. [Clinical experience using hexacetonide triamcinolone in the local treatment of rheumatism].
    Fernández del Vallado P; Gijón Baños J; Beltrán Gutiérrez J; Corts Giner JR
    Rev Clin Esp; 1968 Jul; 110(2):137-40. PubMed ID: 5307055
    [No Abstract]   [Full Text] [Related]  

  • 2. [Erbium 169 synoviortheses and infiltrations of triamcinolone hexacetonide in metatarsophalangeal arthritis of chronic inflammatory rheumatism].
    Bouvier M; Bouysset M; Bonvoisin B; Diaine A; Lejeune E
    Rev Rhum Mal Osteoartic; 1983 Apr; 50(4):267-71. PubMed ID: 6603649
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Injections and local infiltrations of triamcinolone hexacetonide (Lederle) in rheumatology].
    De Usobiaga JL
    Rev Esp Reum Enferm Osteoartic; 1970 Apr; 13(6):349-59. PubMed ID: 5312335
    [No Abstract]   [Full Text] [Related]  

  • 4. Triamcinolone hexacetonide for intraarticular and intramuscular therapy.
    Clemmesen S
    Acta Rheumatol Scand; 1971; 17(4):273-8. PubMed ID: 5316553
    [No Abstract]   [Full Text] [Related]  

  • 5. [On treatment of skin diseases with triamcinolone hexacetonide].
    Schnellen B
    Z Allgemeinmed; 1969 Feb; 45(5):214-6. PubMed ID: 4238975
    [No Abstract]   [Full Text] [Related]  

  • 6. Use of triamcinolone hexacetonide for the treatment of osteoarthritis of the hip: comment on the letter by Margules.
    Kahn C
    Arthritis Rheum; 2002 Sep; 46(9):2546-7; author reply 2547. PubMed ID: 12355514
    [No Abstract]   [Full Text] [Related]  

  • 7. [Experience gained with the use of local administration of medicinal remedies in rheumatic diseases].
    Taran AI; Puzanova OG; Lapenko OIe; Sol's'kyĭ VI; Samoĭlova SM
    Lik Sprava; 2001; (5-6):182-5. PubMed ID: 11881370
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of intra-articular triamcinolone hexacetonide and triamcinolone acetonide in oligoarticular juvenile idiopathic arthritis.
    Zulian F; Martini G; Gobber D; Agosto C; Gigante C; Zacchello F
    Rheumatology (Oxford); 2003 Oct; 42(10):1254-9. PubMed ID: 12810938
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reversal of intractable pericarditis by triamcinolone hexacetonide.
    Buselmeier TJ
    Arch Intern Med; 1977 Apr; 137(4):542. PubMed ID: 849086
    [No Abstract]   [Full Text] [Related]  

  • 10. [Clinical experience of triamcinolone-acetonide in the treatment for alopecia areata].
    Morito S; Kawamura Y; Shimizu M
    Acta Dermatol Kyoto Engl Ed; 1968 Nov; 63(4):375-80. PubMed ID: 5756553
    [No Abstract]   [Full Text] [Related]  

  • 11. Preliminary experience with triamcinolone acetonide during pregnancy.
    Dombrowski MP; Brown CL; Berry SM
    J Matern Fetal Med; 1996; 5(6):310-3. PubMed ID: 8972405
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Triamcinolone hexacetonide. A new corticosteroid for intra-articular therapy.
    Kendall PH
    Ann Phys Med; 1967 May; 9(2):55-8. PubMed ID: 6026698
    [No Abstract]   [Full Text] [Related]  

  • 13. [Intra-articular therapy with triamcinolone hexacetonide].
    Astorga G
    Rev Med Chil; 1967 Aug; 95(8):461-7. PubMed ID: 5614319
    [No Abstract]   [Full Text] [Related]  

  • 14. Intra-articular steroid therapy with triamcinolone acetonide in low dosage.
    SPERLING IL
    Postgrad Med; 1960 Feb; 27():232-4. PubMed ID: 13833284
    [No Abstract]   [Full Text] [Related]  

  • 15. Systemic effects of intraarticular administration of triamcinolone hexacetonide.
    Weiss S; Kisch ES; Fischel B
    Isr J Med Sci; 1983 Jan; 19(1):83-4. PubMed ID: 6832957
    [No Abstract]   [Full Text] [Related]  

  • 16. [Treatment of lumbosciatica from disk hernia by nucleorthesis with triamcinolone hexacetonide].
    Bourgeois P; Frot B; Folinais D; David M; Benacerraf R; Palazzo E; Vigneron AM; Kahn MF
    Presse Med; 1986 Nov; 15(41):2073. PubMed ID: 2949234
    [No Abstract]   [Full Text] [Related]  

  • 17. Prospective use of intramuscular triamcinolone acetonide in pseudogout.
    Roane DW; Harris MD; Carpenter MT; Finger DR; Jarek MJ; Alloway JA; Erickson AR; Venanzi WE; Drehmer TJ
    J Rheumatol; 1997 Jun; 24(6):1168-70. PubMed ID: 9195527
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Triamcinolone acetonide in ocular therapeutics.
    Jermak CM; Dellacroce JT; Heffez J; Peyman GA
    Surv Ophthalmol; 2007; 52(5):503-22. PubMed ID: 17719372
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of mitoxantrone and intrathecal triamcinolone acetonide treatment in chronic progressive multiple sclerosis patients.
    Hellwig K; Schimrigk S; Lukas C; Hoffmann V; Brune N; Przuntek H; Müller T
    Clin Neuropharmacol; 2006; 29(5):286-91. PubMed ID: 16960474
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Visual acuity and intraocular pressure after high-dose intravitreal triamcinolone acetonide in selected ocular diseases.
    Jonas JB; Schlichtenbrede F
    Eye (Lond); 2008 Jul; 22(7):869-73. PubMed ID: 17304257
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.